Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
UK eligibility follows NICE guidance: typically for type 2 diabetes with inadequate glycaemic control or obesity with BMI 35 kg/m (or lower thresholds for certain ethnic groups) plus weight-related comorbidities
Notable initiatives include Sun Pharmas launch of liraglutide biosimilars in India and Glenmarks Lirafit, which reflect efforts to improve affordability
Carrying a copy of your prescription is a good idea, though it is rarely requested
For example, patients using semaglutide achieve an average weight loss of 4.5 kg, which compares favorably to clinical trial results ranging from 3.5 to 6.5 kg
QTc prolongation is caused by drugs used to treat diabetes, schizophrenia, and other psychiatric conditions [14]
Chemical modifications can improve stability, alter pharmacokinetics, or enhance target selectivity, potentially addressing traditional limitations of peptide drugs
US$ 22.93
US$ 25.01
US$ 27.02
US$ 23.32
